Literature DB >> 26608313

Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans.

Maria Fernanda de Castro-Amarante1, Cynthia A Pise-Masison2, Katherine McKinnon1, Robyn Washington Parks1, Veronica Galli1, Maria Omsland3, Vibeke Andresen4, Raya Massoud5, Giovanna Brunetto5, Breanna Caruso5, David Venzon6, Steven Jacobson5, Genoveffa Franchini2.   

Abstract

UNLABELLED: Because the viral DNA burden correlates with disease development, we investigated the contribution of monocyte subsets (classical, intermediate, and nonclassical monocytes) to the total viral burden in 22 human T cell leukemia virus type 1 (HTLV-1)-infected individuals by assessing their infectivity status, frequency, as well as chemotactic and phagocytic functions. All three monocyte subsets sorted from HTLV-1-infected individuals were positive for viral DNA, and the frequency of classical monocytes was lower in the blood of HTLV-1-infected individuals than in that of uninfected individuals, while the expression levels of the chemokine receptors CCR5, CXCR3, and CX3CR1 in classical monocytes were higher in HTLV-1-infected individuals than uninfected individuals; the percentage of intermediate monocytes and their levels of chemokine receptor expression did not differ between HTLV-1-infected and uninfected individuals. However, the capacity of intermediate monocytes to migrate to CCL5, the ligand for CCR5, was higher, and a higher proportion of nonclassical monocytes expressed CCR1, CXCR3, and CX3CR1. The level of viral DNA in the monocyte subsets correlated with the capacity to migrate to CCL2, CCL5, and CX3CL1 for classical monocytes, with lower levels of phagocytosis for intermediate monocytes, and with the level of viral DNA in CD8(+) and CD4(+) T cells for nonclassical monocytes. These data suggest a model whereby HTLV-1 infection augments the number of classical monocytes that migrate to tissues and become infected and the number of infected nonclassical monocytes that transmit virus to CD4(+) and CD8(+) T cells. These results, together with prior findings in a macaque model of HTLV-1 infection, support the notion that infection of monocytes by HTLV-1 is likely a requisite for viral persistence in humans. IMPORTANCE: Monocytes have been implicated in immune regulation and disease progression in patients with HTLV-1-associated inflammatory diseases. We detected HTLV-1 DNA in all three monocyte subsets and found that infection impacts surface receptor expression, migratory function, and subset frequency. The frequency of nonclassical patrolling monocytes is increased in HTLV-1-infected individuals, and they have increased expression of CCR1, CXCR3, and CX3CR1. The viral DNA level in nonclassical monocytes correlated with the viral DNA level in CD4(+) and CD8(+) T cells. Altogether, these data suggest an increased recruitment of classical monocytes to inflammation sites that may result in virus acquisition and, in turn, facilitate virus dissemination and viral persistence. Our findings thus provide new insight into the importance of monocyte infection in viral spread and suggest targeting of monocytes for therapeutic intervention.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26608313      PMCID: PMC4810698          DOI: 10.1128/JVI.02735-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  89 in total

1.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.

Authors:  M Nagai; K Usuku; W Matsumoto; D Kodama; N Takenouchi; T Moritoyo; S Hashiguchi; M Ichinose; C R Bangham; S Izumo; M Osame
Journal:  J Neurovirol       Date:  1998-12       Impact factor: 2.643

2.  Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features.

Authors:  K Eguchi; N Matsuoka; H Ida; M Nakashima; M Sakai; S Sakito; A Kawakami; K Terada; H Shimada; Y Kawabe
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

3.  The chemokine CX3CL1 reduces migration and increases adhesion of neurons with mechanisms dependent on the beta1 integrin subunit.

Authors:  Clotilde Lauro; Myriam Catalano; Flavia Trettel; Fabrizio Mainiero; Maria Teresa Ciotti; Fabrizio Eusebi; Cristina Limatola
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  HTLV-1 and polymyositis in Jamaica.

Authors:  O S Morgan; P Rodgers-Johnson; C Mora; G Char
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

Review 5.  Inflammatory manifestations of HTLV-1 and their therapeutic options.

Authors:  Fabiola Martin; Graham P Taylor; Steven Jacobson
Journal:  Expert Rev Clin Immunol       Date:  2014-11       Impact factor: 4.473

6.  Peripheral monocytes of obese women display increased chemokine receptor expression and migration capacity.

Authors:  P Krinninger; R Ensenauer; K Ehlers; K Rauh; J Stoll; S Krauss-Etschmann; H Hauner; H Laumen
Journal:  J Clin Endocrinol Metab       Date:  2014-02-25       Impact factor: 5.958

7.  Fractalkine is not a major chemoattractant for the migration of neutrophils across microvascular endothelium.

Authors:  G Ch Beck; F Ludwig; J Schulte; K van Ackern; F J van der Woude; B A Yard
Journal:  Scand J Immunol       Date:  2003-08       Impact factor: 3.487

8.  Viral Source-Independent High Susceptibility of Dendritic Cells to Human T-Cell Leukemia Virus Type 1 Infection Compared to That of T Lymphocytes.

Authors:  Sandrine Alais; Renaud Mahieux; Hélène Dutartre
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

9.  Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica.

Authors:  Akiyuki Uzawa; Masahiro Mori; Sei Hayakawa; Saeko Masuda; Fumio Nomura; Satoshi Kuwabara
Journal:  BMC Neurol       Date:  2010-11-11       Impact factor: 2.474

10.  Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues.

Authors:  R T Palframan; S Jung; G Cheng; W Weninger; Y Luo; M Dorf; D R Littman; B J Rollins; H Zweerink; A Rot; U H von Andrian
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

View more
  25 in total

1.  Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice.

Authors:  Veronica Galli; Christopher C Nixon; Natasa Strbo; Maria Artesi; Maria F de Castro-Amarante; Katherine McKinnon; Dai Fujikawa; Maria Omsland; Robyn Washington-Parks; Laura Romero; Breanna Caruso; Keith Durkin; Sophia Brown; Baktiar Karim; Monica Vaccari; Steve Jacobson; Jerome A Zack; Anne Van den Broeke; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

2.  Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ.

Authors:  Manraj Singh Narulla; Ahlam Alsairi; Lucie Charmier; Stephen Noonan; David Conroy; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

Review 3.  HTLV-1: A real pathogen or a runaway guest of a diseased cell?

Authors:  L I B Kanzaki
Journal:  J Biosci       Date:  2018-09       Impact factor: 1.826

Review 4.  Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission.

Authors:  Christine Gross; Andrea K Thoma-Kress
Journal:  Viruses       Date:  2016-03-09       Impact factor: 5.048

Review 5.  HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ.

Authors:  Chou-Zen Giam; Oliver John Semmes
Journal:  Viruses       Date:  2016-06-16       Impact factor: 5.048

6.  Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo.

Authors:  Rie Furuta; Jun-Ichirou Yasunaga; Michi Miura; Kenji Sugata; Akatsuki Saito; Hirofumi Akari; Takaharu Ueno; Norihiro Takenouchi; Jun-Ichi Fujisawa; Ki-Ryang Koh; Yusuke Higuchi; Mohamed Mahgoub; Masakazu Shimizu; Fumihiko Matsuda; Anat Melamed; Charles R Bangham; Masao Matsuoka
Journal:  PLoS Pathog       Date:  2017-11-29       Impact factor: 6.823

7.  Quantitating the Transfer of the HTLV-1 p8 Protein Between T-Cells by Flow Cytometry.

Authors:  Norbert Donhauser; Stefanie Heym; Andrea K Thoma-Kress
Journal:  Front Microbiol       Date:  2018-03-07       Impact factor: 5.640

Review 8.  Human T-cell leukaemia virus type 1: parasitism and pathogenesis.

Authors:  Charles R M Bangham; Masao Matsuoka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

Review 9.  Functional properties and sequence variation of HTLV-1 p13.

Authors:  Maria Omsland; Micol Silic-Benussi; Ramona Moles; Sarkis Sarkis; Damian F J Purcell; David Yurick; Georges Khoury; Donna M D'Agostino; Vincenzo Ciminale; Genoveffa Franchini
Journal:  Retrovirology       Date:  2020-05-12       Impact factor: 4.602

10.  A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells.

Authors:  Sebastian Millen; Lina Meretuk; Tim Göttlicher; Sarah Schmitt; Bernhard Fleckenstein; Andrea K Thoma-Kress
Journal:  Retrovirology       Date:  2020-09-10       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.